Eduardo Bruno Martins insider trades

Open-market stock purchases and sales by Eduardo Bruno Martins, Chief Medical Officer at Sagimet Biosciences Inc, from SEC Form 4 filings since Mar 23, 2016.

Recent trades

DateStockTradeValue
Feb 19, 2026SGMT Sagimet Biosciences IncBought (not open market)—
Feb 19, 2026SGMT Sagimet Biosciences IncBought (not open market)—
Feb 10, 2026SGMT Sagimet Biosciences IncSold$19.5K

Companies traded

  • SGMT Sagimet Biosciences Inc: 3 sales, last Feb 19, 2026
  • EIGR Eiger BioPharmaceuticals, Inc: other filings, last Mar 9, 2017

Get free alerts when Eduardo Bruno Martins files a new trade →